Neutrophils discriminate between lipopolysaccharides of different bacterial sources and selectively release neutrophil extracellular traps

by Elmar Pieterse, Nils Rother, Cansu Yanginlar, Luuk Hilbrands, Johan Van Der Vlag
Published 2016-11-01

Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients

by Baranca Buijsers, Cansu Yanginlar, Marissa L. Maciej-Hulme, Quirijn de Mast, Johan van der Vlag
Published 2020-09-01

Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies

by Markus A. Loeven, Marissa L. Maciej-Hulme, Cansu Yanginlar, Melanie C. Hubers, Edwin Kellenbach, Mark de Graaf, Toin H. van Kuppevelt, Jack Wetzels, Ton J. Rabelink, Richard J. H. Smith, Johan van der Vlag
Published 2021-08-01

Increased Plasma Heparanase Activity in COVID-19 Patients

by Baranca Buijsers, Cansu Yanginlar, Aline de Nooijer, Inge Grondman, Marissa L. Maciej-Hulme, Inge Jonkman, Nico A. F. Janssen, Nils Rother, Mark de Graaf, Peter Pickkers, Peter Pickkers, Matthijs Kox, Matthijs Kox, Leo A. B. Joosten, Tom Nijenhuis, Mihai G. Netea, Mihai G. Netea, Luuk Hilbrands, Frank L. van de Veerdonk, Raphaël Duivenvoorden, Raphaël Duivenvoorden, Quirijn de Mast, Johan van der Vlag
Published 2020-10-01